Standard BioTools Inc. (LAB)
NASDAQ: LAB · Real-Time Price · USD
1.020
-0.040 (-3.77%)
At close: Mar 5, 2026, 4:00 PM EST
1.040
+0.020 (1.96%)
After-hours: Mar 5, 2026, 5:47 PM EST
Standard BioTools Employees
As of December 31, 2024, Standard BioTools had 818 total employees, including 814 full-time and 4 part-time employees. The number of employees increased by 279 or 51.76% compared to the previous year.
Employees
818
Change (1Y)
279
Growth (1Y)
51.76%
Revenue / Employee
$104,317
Profits / Employee
-$91,560
Market Cap
392.26M
Employees Chart
Related Stocks
| Company Name | Employees |
|---|---|
| Orthofix Medical | 1,605 |
| Viemed Healthcare | 1,380 |
| Cerus | 630 |
| OrthoPediatrics | 562 |
| RxSight | 498 |
| Pacific Biosciences of California | 485 |
| Beta Bionics | 423 |
| NeuroPace | 209 |
LAB News
- 9 days ago - Standard BioTools Reports Fourth Quarter and Full Year 2025 Financial Results - GlobeNewsWire
- 23 days ago - Standard BioTools to Announce Fourth Quarter and Full Year 2025 Financial Results on February 24, 2026 - GlobeNewsWire
- 4 weeks ago - Standard BioTools Completes Sale of SomaLogic to Illumina - GlobeNewsWire
- 2 months ago - Standard BioTools Announces Preliminary Fourth Quarter and Full Year 2025 Revenue - GlobeNewsWire
- 3 months ago - Molecular Instruments and Standard BioTools Announce Collaboration to Bring Amplified Multi-Omic Readouts to Imaging Mass Cytometry - Business Wire
- 4 months ago - Illumina® Protein Prep delivers groundbreaking precision in NGS proteomics for more than 40 customers, ranging from academic institutions to large national biobanks - PRNewsWire
- 4 months ago - Standard BioTools Reports Third Quarter 2025 Financial Results - GlobeNewsWire
- 4 months ago - Standard BioTools to Announce Third Quarter Financial Results on November 4, 2025 - GlobeNewsWire